Medpace(MEDP) ZACKS·2025-01-14 00:20Analyst Estimates and Stock Performance - Positive estimate revisions for Medpace indicate optimism about the company's business outlook [1] - Empirical research shows a direct correlation between estimate revisions and impending stock price performance [2] - Medpace currently holds a Zacks Rank of 2 (Buy), with stocks at 1 delivering an average annual return of +25% since 1988 [3] - The consensus EPS projection for Medpace has increased by 0.81% in the past 30 days [3] Valuation Metrics - Medpace trades at a PEG ratio of 1.8, higher than the industry average of 1.41 [4] - The company's Forward P/E ratio is 28.25, representing a premium compared to the industry average of 17.02 [8] Industry and Sector Performance - The Medical Services industry, part of the Medical sector, has a Zacks Industry Rank of 154, placing it in the bottom 39% of over 250 industries [4] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1 [5] Recent Stock Performance - Medpace's stock closed at 2.97 per share, representing year-over-year growth of 20.73% [7] - The latest consensus estimate predicts revenue of $536.37 million, indicating a 7.62% increase compared to the same quarter of the previous year [7]